What is xerosis in patients with diabetes?

What is Xerosis in Diabetics?

Xerosis in diabetic patients is abnormally dry skin that results from autonomic neuropathy affecting sweat gland function, leading to reduced skin hydration, fissuring, and increased susceptibility to infection and ulceration. This condition is explicitly recognized as a manifestation of diabetic autonomic neuropathy 1.

Pathophysiology and Clinical Significance

Xerosis develops as part of the spectrum of diabetic autonomic neuropathy complications. The Chinese diabetes guidelines specifically list "dry skin" (xerosis) alongside anhidrosis, heat intolerance, and hyperhidrosis as autonomic neuropathy manifestations 1. This occurs because:

• Autonomic nerve damage impairs sweat gland function, reducing the skin's natural moisture barrier
• Chronic hyperglycemia disrupts skin barrier integrity, affecting stratum corneum maturation and function 2
• The condition exists on a continuum from mild "dry skin" sensation to severe xerosis with ichthyosiform presentations, particularly on the shins and feet 2

Clinical Presentation and Distribution

Xerosis in diabetes presents with characteristic features:

• Most commonly affects the lower extremities, especially shins and feet 2
• Manifests as dry, scaly, rough skin that may progress to fissuring 3, 4
• Can be accompanied by pruritus (itching), which serves as an independent predictor of future diabetes development (OR 3.41) 3
• Fissured xerotic skin is particularly prevalent, affecting 53.6-77.9% of diabetic patients in recent studies 5, 4

Clinical Importance for Morbidity and Mortality

Xerosis is not merely a cosmetic concern—it directly increases risk of serious complications:

• Fissured dry skin creates entry points for bacteria, predisposing to diabetic foot infections 6
• Compromised skin barrier increases infection risk, which is the leading cause of diabetes-related hospitalization and lower extremity amputation 7
• Xerosis serves as an early warning sign: it is an independent predictor of future diabetes development (OR 4.70) 3, making it valuable for risk stratification

Management Approach

Well-controlled blood glucose is the foundation, as it may delay progression of diabetic neuropathy and its manifestations including xerosis 1.

Specific Treatment Strategy:

1. Optimize glycemic control - Poor control (HbA1c >7%) correlates with more severe skin manifestations 3

2. Daily skin care regimen:

   • Apply ceramide-containing moisturizers twice daily to affected areas 8
   • Use gentle cleansers to avoid further barrier disruption 8
   • Focus particularly on feet, shins, and hands 8

3. Foot-specific care (given high-risk location):

   • Daily foot inspection for fissures or breaks in skin integrity 1
   • Comprehensive foot examination annually for all diabetic patients 1
   • Immediate attention to any skin breaks to prevent infection progression

4. Address underlying neuropathy when present with appropriate medications (pregabalin, gabapentin, duloxetine, etc.) 1

Critical Pitfalls to Avoid

• Do not dismiss xerosis as trivial - it represents underlying autonomic dysfunction and increases infection risk
• Do not overlook foot xerosis - this location has the highest risk for progression to ulceration and amputation
• Do not wait for severe manifestations - early aggressive moisturization prevents fissuring and complications
• Do not ignore xerosis in prediabetic patients - it may indicate evolving metabolic dysfunction requiring intervention 3

The presence of xerosis should prompt evaluation of overall diabetes control, screening for other neuropathic complications, and implementation of preventive skin care measures to reduce the substantial morbidity associated with diabetic foot complications.